1-4 of 4
Nimish Shah, MD
Close
Sort by
Journal Articles

Procarbazine-Free Escalated Beacopdac in Frontline Therapy of Advanced Hodgkin Lymphoma Reduces Red Cell Transfusion Requirements and May Shorten Time to Menstrual Period Recovery Compared to Escalated Beacopp and Appears to be As Efficacious

Anna Santarsieri, MBBS, Katherine Sturgess, MA, MBBChir, MRCP, MSc, Pauline Brice, Tobias F Menne, MD PhD FRCPath, Wendy Osborne, MD, Thomas Creasey, MBBS, Kirit M. Ardeshna, MA, MD FRCP, FRCPath, Sarah Behan, Stephen Booth, MA,MBBChir,MRCP,FRCPath, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Kate Cwynarski, PhDMD, Sunil Iyengar, MD, Stephen G Jones, Deirdre O'Mahony, MD, Nicolas Martinez-Calle, MD MSc, Pamela McKay, MD, Sateesh K Nagumantry, BM BCh, John Rudge, MA, PhD, Nimish Shah, MD, Gwyneth Stafford, Alexander Sternberg, Benjamin J Uttenthal, MD PhD, Andrew K McMillan, FRCP, George A Follows, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1564.
https://doi.org/10.1182/blood-2019-125256
Published: 2019
Journal Articles

Advanced-Stage Hodgkin Lymphoma in the East of England Cancer Network: A 10-Year Comparative Analysis of Outcomes for Patients Treated with ABVD or Escalated BEACOPP in the Non-Trial Setting Compared with Age-Matched Patients Treated in the Multinational RATHL Trial

James Russell, MD, Angela Collins, MD, Alexis Fowler, MD, Mamatha Karanth, MD, Isabel Lentell, MD, Chandan Saha, MD, Suzanne Docherty, MD, Joseph Padayatty, MD, Kyaw Maw, MD, Lisa Cooke, MD, Andrew Hodson, MD, Nimish Shah, MD, Shalal Sadullah, MD, Nicholas Grigoropoulos, MD PhD, Wendi Qian, Amy A Kirkwood, Benjamin J Uttenthal, MD PhD, Peter Johnson, MD FRCP, George A Follows, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 735.
https://doi.org/10.1182/blood.V130.Suppl_1.735.735
Published: 2017
Journal Articles

A Phase I Study Of The Oral Btk Inhibitor ONO-4059 In Patients With Relapsed/Refractory B-Cell Lymphoma

Simon Rule, MD, Nimish Shah, MD, Gilles Andre Salles, MD, PhD, Lionel Karlin, MD, Franck Morschhauser, MD, PhD, Louis Terriou, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Claire Hutchinson, BMedSci, MRCP, FRCPath, Chris Fegan, MBBS, Guillaume Cartron, MD, PhD, Tomasz Knurowski, MD, James G Wright, PhD, Andrew J Saunders, MD, Hideyuki Honda, Bsc, Andrew Mazur, Toshio Yoshizawa, PhD, Kazuhito Kawabata, PhD, Joseph TP Birkett, PhD
Journal: Blood
Blood (2013) 122 (21): 4397.
https://doi.org/10.1182/blood.V122.21.4397.4397
Published: 2013
Journal Articles

A Phase I Study Of The Oral Btk Inhibitor ONO-4059 In Patients With Relapsed/Refractory and High Risk Chronic Lymphocytic Leukaemia (CLL)

Gilles Andre Salles, MD, PhD, Lionel Karlin, MD, Simon Rule, MD, Nimish Shah, MD, Franck Morschhauser, MD, PhD, Louis Terriou, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Claire Hutchinson, BMedSci, MRCP, FRCPath, Chris Fegan, MBBS, Guillaume Cartron, MD, PhD, Tomasz Knurowski, MD, Andrew J Saunders, MD, James G Wright, PhD, Hideyuki Honda, Bsc, Andrew Mazur, Toshio Yoshizawa, PhD, Kazuhito Kawabata, PhD, Joseph TP Birkett, PhD
Journal: Blood
Blood (2013) 122 (21): 676.
https://doi.org/10.1182/blood.V122.21.676.676
Published: 2013